Navigation Links
Nature Medicine study shows Peregrine's bavituximab can cure lethal virus infections
Date:11/23/2008

TUSTIN, Calif., November 23, 2008 -- Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) today reported publication of data in Nature Medicine that supports the broad anti-viral potential of the company's novel anti-phosphatidylserine (anti-PS) antibody platform, showing that its PS-targeting drug bavituximab can cure lethal virus infections in animal disease models.

Bavituximab is in clinical trials for the treatment of hepatitis C virus (HCV) infection and in preclinical development for the treatment of viral hemorrhagic fevers under a contract worth up to $44.4 million with the bioterrorism program of the U.S. Defense Threat Reduction Agency (DTRA). Bavituximab and other anti-PS antibodies are also being studied preclinically in HIV, cytomegalovirus (CMV) and other serious viral infections.

"Based on these findings, anti-PS antibodies such as bavituximab may represent a completely new class of drugs for the treatment of life-threatening viral infections," said study co-author Dr. Philip Thorpe, professor of pharmacology at UT Southwestern Medical Center and a scientific advisor to Peregrine. "By targeting a property of the host cell rather than the virus itself, anti-PS antibodies have the potential to treat a range of viral infections, and they should be less susceptible to the viral mutations that contribute to the development of drug resistance."

In the research reported today, scientists at UT Southwestern assessed the activity of bavituximab in animal models of two lethal viruses--cytomegalovirus and Lassa fever virus, a hemorrhagic fever virus that is listed as a class A bioterrorism agent by the CDC. Bavituximab showed potent anti-viral activity in both models.

Dr. Melina Soares, lead study author and UT Southwestern instructor of pharmacology, commented, "Recent non-affiliated research has further confirmed that exposed PS has immunosuppressive properties and is also clarifying its involvement during vi
'/>"/>

Contact: Barbara Lindheim
blindheim@biocompartners.com
212-918-4650
BioCom Partners
Source:Eurekalert

3

GOOD

Page: 1 2 3

Related biology news :

1. Nature study demonstrates that bacterial clotting depends on clustering
2. Extreme nature helps scientists design nano materials
3. Sirtris review of sirtuin therapeutics for diseases of aging in Nature Reviews Drug Discovery
4. Cancer signatures uncovered
5. Nature publishes new evidence about the deep biosphere written by biogeoscientists
6. Dartmouth researchers discover gene signatures for scleroderma
7. Scattered nature of Wisconsins woodlands could complicate forests response to climate change
8. Giving nature a helping hand
9. A molecular switch turns on the flame in natures blowtorch
10. Male seahorses are natures Mr. Mom, Texas A&M researchers say
11. Nature paper describes technique for extracting hierarchical structure of networks

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ientists at the California Institute of Technology...emotion-like behavior in the fruit fly, Drosophil...relevant to the relationship between the neurotran...ty disorder (ADHD), are described in the December ... brain contains only about 20,000 neurons and has...
(Date:11/25/2009)...BER 25, 2009 Soil is the linchpin of the environm...meet. Despite that, many students see soil as "jus... Soil science educators are challenged with the ta...e critical importance of soil in the environment. ...arth science teachers at University of Nebraska-Li...
(Date:11/24/2009)... Institute (LRI) today named 12 new grant recipien...cognize innovative work across a broad spectrum of...ivity, novelty, and potential to drive scientific ...he complex disease of systemic lupus. , The 2009...rchers across the nation and include interdiscipli...
Breaking Biology News(10 mins):Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 3Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 4It's not just dirt! 2Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3PEAK Surgical Announces Results of First PRECISE Studies at American College of Surgeons Clinical Congress 5492 1PEAK Surgical Announces Results of First PRECISE Studies at American College of Surgeons Clinical Congress 5492 2PEAK Surgical Announces Results of First PRECISE Studies at American College of Surgeons Clinical Congress 5492 3Inc Magazine Unveils 28th Annual List of Americas Fastest Growing Private Companies the Inc 500 59482 1Inc Magazine Unveils 28th Annual List of Americas Fastest Growing Private Companies the Inc 500 59482 2IDEXX Laboratories to Release 2009 Third Quarter Financial Results 14472 1
... Society for Microbiology (ASM) Eli Lilly and Comp... Newman, Wilson Professor of Biology and Geobiolog...rd recognizes fundamental research of unusual meri...n the threshold of his or her career. , Dr. Newma...ed the field of geomicrobiology. Her seminal resea...
... Society for Microbiology (ASM) William A. Hinton ...ro Casadevall, Chair, Department of Microbiology a..., Yeshiva University, New York. This award recogni... research training of underrepresented minorities ...emplary training and mentoring to a significant nu...
...ociety for Microbiology (ASM) Merck Irving S. Siga...rrell, Assistant Professor, Department of Microbio...ersity of the Health Sciences (USUHS), Bethesda, M... the Merck Irving S. Sigal Memorial Award is prese...ental in the early discovery of therapies to treat...
Other Biology News:American Society for Microbiology honors Dianne K. Newman 2American Society for Microbiology honors Arturo Casadevall 2
(Date:11/25/2009)..., BOSTON, Nov. 25 Biotech firm Rep...nomic data from the 1918 pandemic through the pred... pandemic, today issued its latest biochemical ana...thality of the H1N1 ("Swine Flu") virus has droppe...,s current outbreak in the spring of 2009 to resti...
(Date:11/25/2009)... , ,, BOCA RATON, Fla., Nov. 25 /P... painful year. Not so for BodyLogicMD. The nation...hysicians specializing exclusively in medically su...mber of physicians in its network since Nove...progress to add more physician-owned centers, incl...
(Date:11/25/2009)..., BEIJING, Nov. 25 /PRNewswire-Asia/ -- Sinov...ovider of vaccines, announced today that it execut...ovac (Dalian) Vaccine,Technology Co., Ltd. (Sinova...and commercialize human-use vaccines. Sinovac will...ping and commercializing world-class vaccines; the...
(Date:11/25/2009)... DIEGO, Nov. 25 Ardea Bi...hat Barry D. Quart, Pharm.D., president and chief ...ay 21st Annual Health Care Conference. , ,Present...Annual Health Care Conference,Date: Tuesday, ...,Location: The New York Palace Hotel, New York, N...
Breaking Biology Technology:Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 4Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2
...nference Call Tomorrow (Tuesday) at 8:30 am EDT to... Valley Cottage, NEW YORK, September 10 XTL,Biop...E: XTL) today announced,the initiation of a Phase ... norepinephrine reuptake inhibitor (SNRI) - for th...ine is being developed for the treatment of diabet...
...ltern, a leading global research,organization, is ...,Chiltern,s Country Manager for the Czech Republic...e year award. The award ceremony was held in,Londo...om amongst his peers by a panel of judges who,revi...ccessful conclusion,of clinical trials. The judgin...
Wyeth Sets Webcast and Conference Call for 2007 Third Quarter Earnings
Other Biology Technology:XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 2XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 3XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 4XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 5XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 6XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 7Richard Schulz Receives the Coveted GCPj Award for Best Clinical Researcher of the Year 2
Goat Anti-Mouse IGSF4 Polyclonal Antibody, Unconjugated from R&D Systems
Rat Anti-Mouse Activin RIB / ALK-4 Monoclonal Antibody, Unconjugated, Clone 207304 from R&D Systems
Normal Human Serum from 3H Biomedical AB
...s for SYBR Green, TaqMan, LNA spiked TaqMan, Methy...ghly specific primers are designed by avoiding cro...BLAST search results. Primer efficiency is enhance...fied by connecting to the Mfold server. Beacon Des...
Biology Products: